BROKENSHIRE COLLEGE

Madapo, Davao City

DRUG STUDY
Name of Client: Estuita, Floranimfa___________ Age: _52_ Sex: F_ Date of Birth: __________ Marital Status: Married Religion: ________________________
Chief Complaint/ Reason for Admission: __Difficulty Speaking______________________________________________________________________________________
Date and Time of Admission: ______________________________________________________ Accompanied by/ Informant: Patient______________________________
Medical Diagnosis/ Impression: S/P Total Thryoidectomy (9/28) _________________________ Operation Perform (if any): ____________________________
GENERIC BRAND GENERAL MECHANISM OF ROUTE OF INDICATION CONTRAINDICATION ADVERSE NURSING
NAME NAME CLASSIFICATION ACTION DOSAGE REACTION RESPONSIBILITY
Calcitriol (Rx) Rocaltrol ; Vitamin D Analog Calcitriol is a potent metabolite capsule Predialysis Patients Patients with the following conditions: Frequency Not Defined -Instruct patient to protect
Calcijex; to the active form of vitamin D,  0.25mcg Rocaltrol (calcitriol) is indicated in  sarcoidosis  Abdominal pain medication from light, heat and
which in turn controls the the management of moisture.
reabsorption of calcium by the
 0.5mcg secondary hyperparathyroidism and  high amount of phosphate in  Apathy
kidneys, controls the intestinal
oral solution resultant metabolic bone disease in the blood  BUN and creatinine - Advise patient:
absorption of dietary calcium;  1mcg/mL patients with moderate to  high amount of calcium increased • to include foods high in calcium
decreases excessive serum severe chronic renal failure (Ccr 15 in the blood  Cardiac arrhythmia and phosphate.
phosphate levels, bone to 55 mL/min) not yet on dialysis..  excessive amount of  Constipation • to avoid foods high in sodium
resorption, and parathyroid vitamin D in the body or potassium.
 Dry mouth • to increase fluids, unless
hormone levels Dialysis Patients  blockage of the arteries called
Rocaltrol (calcitriol) is indicated arteriosclerosis  Dehydration advised not to by health care
in the management of
 kidney stones  Growth suppression provider.
hypocalcemia and the resultant
 kidney disease with reduction  Headache - Monitor for hypercalcemia.
metabolic bone disease in patients
undergoing chronic renal dialysis. in kidney function  Hyperthermia (Hypercalcemia is a sign of
 Hypercalcemia calcitriol overdose.)
Hypoparathyroidism Patients
Patients allergic to Vitamin D Analogue  Hypercholesteremia
-Monitor vitamin D intake.
Rocaltrol (calcitriol) is also  Hypermagnesemia (Excessive intake of vitamin D
indicated in the management  Hyperphosphatemia may lead to hypercalcemia.)
of hypocalcemia and its clinical
manifestations in patients with
 Hypertension
- Instruct patient and caregiver to
postsurgicalhypoparathyroidism,  Libido decreased monitor for and report: headache,
idiopathic hypoparathyroidism,  Metallic taste weakness, irritability,
and pseudohypoparathyroidism.  Muscle or bone pain somnolence, conjunctivitis,
 N/V photophobia, rhinorrhea,
anorexia,
 Nocturia

Submitted by: __Alexa Lexington Rae Zagado, SNBC______________________ Clinical Instructor: Mr. Cresencio Cajigal, RN, MN_________________________
Year and Section: _BSN III_____________________________________________ Date Submitted: _October 10, 2019_____________________________________